UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7582) 7582
Magazine Article (44) 44
Book Chapter (27) 27
Dissertation (4) 4
Newsletter (2) 2
Publication (2) 2
Book / eBook (1) 1
Book Review (1) 1
Conference Proceeding (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6545) 6545
science & technology (4136) 4136
life sciences & biomedicine (4049) 4049
male (3650) 3650
trimethoprim, sulfamethoxazole drug combination - therapeutic use (3494) 3494
female (3278) 3278
adult (2519) 2519
middle aged (1941) 1941
trimethoprim, sulfamethoxazole drug combination (1461) 1461
infectious diseases (1338) 1338
aged (1190) 1190
anti-infective agents - therapeutic use (1175) 1175
anti-bacterial agents - therapeutic use (1164) 1164
trimethoprim, sulfamethoxazole drug combination - adverse effects (1048) 1048
child (1017) 1017
abridged index medicus (1011) 1011
microbiology (965) 965
adolescent (950) 950
trimethoprim, sulfamethoxazole drug combination - administration & dosage (934) 934
trimethoprim - therapeutic use (920) 920
sulfamethoxazole - therapeutic use (879) 879
trimethoprim, sulfamethoxazole drug combination - pharmacology (860) 860
drug combinations - therapeutic use (830) 830
child, preschool (811) 811
microbial sensitivity tests (794) 794
trimethoprim-sulfamethoxazole (758) 758
treatment outcome (740) 740
aids/hiv (739) 739
infant (728) 728
antibiotics (692) 692
drug therapy, combination (679) 679
animals (678) 678
immunology (668) 668
pneumonia, pneumocystis - drug therapy (668) 668
anti-bacterial agents - pharmacology (667) 667
general & internal medicine (656) 656
medicine, general & internal (622) 622
pharmacology & pharmacy (610) 610
trimethoprim (600) 600
retrospective studies (569) 569
risk factors (549) 549
sulfamethoxazole (525) 525
infections (474) 474
urinary tract infections - drug therapy (463) 463
pneumonia, pneumocystis - prevention & control (452) 452
anti-infective agents - adverse effects (416) 416
health aspects (414) 414
drug therapy (397) 397
pediatrics (390) 390
drug resistance, microbial (380) 380
research article (375) 375
hiv (366) 366
drug resistance (364) 364
prospective studies (350) 350
pneumonia (348) 348
aged, 80 and over (344) 344
time factors (333) 333
trimethoprim - adverse effects (328) 328
recurrence (317) 317
anti-infective agents, urinary - therapeutic use (315) 315
hiv infections - drug therapy (315) 315
hiv infections - complications (314) 314
sulfamethoxazole - adverse effects (314) 314
aids-related opportunistic infections - drug therapy (301) 301
anti-infective agents - administration & dosage (297) 297
care and treatment (290) 290
research (284) 284
drug combinations - adverse effects (283) 283
aids-related opportunistic infections - prevention & control (277) 277
administration, oral (276) 276
anti-bacterial agents - administration & dosage (276) 276
trimethoprim - pharmacology (276) 276
co-trimoxazole (275) 275
nocardia infections - drug therapy (274) 274
follow-up studies (272) 272
acute disease (270) 270
young adult (269) 269
drug resistance, bacterial (268) 268
acquired immunodeficiency syndrome - complications (266) 266
diagnosis, differential (266) 266
sulfamethoxazole - pharmacology (260) 260
bacterial infections and mycoses (257) 257
trimethoprim - administration & dosage (257) 257
public, environmental & occupational health (249) 249
pentamidine - therapeutic use (247) 247
drug administration schedule (243) 243
patients (240) 240
sulfamethoxazole - administration & dosage (239) 239
immunocompromised host (237) 237
children (236) 236
bacteria (233) 233
urinary tract infections - microbiology (227) 227
drug combinations - pharmacology (225) 225
aids (223) 223
escherichia coli - drug effects (222) 222
prophylaxis (220) 220
pneumonia, pneumocystis - complications (218) 218
drug combinations - administration & dosage (215) 215
double-blind method (212) 212
mortality (212) 212
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6772) 6772
French (241) 241
Spanish (222) 222
German (167) 167
Japanese (128) 128
Portuguese (53) 53
Turkish (43) 43
Italian (39) 39
Polish (39) 39
Dutch (35) 35
Russian (28) 28
Chinese (25) 25
Korean (12) 12
Danish (11) 11
Hebrew (10) 10
Czech (7) 7
Norwegian (7) 7
Swedish (7) 7
Hungarian (6) 6
Romanian (6) 6
Slovak (6) 6
Croatian (4) 4
Finnish (3) 3
Bulgarian (2) 2
Afrikaans (1) 1
Icelandic (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antimicrobial agents and chemotherapy, ISSN 1098-6596, 05/2012, Volume 56, Issue 5, pp. 2518 - 2523
Recent exposure to azoles is an important risk factor for infection with fluconazole-resistant spp., but little is known about the role of antibacterial drug... 
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Candida glabrata - physiology | Coinfection | Prospective Studies | Carbapenems - administration & dosage | Humans | Middle Aged | Bacteria - drug effects | Fluconazole - administration & dosage | Candidiasis - microbiology | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Bacteria - growth & development | Clindamycin - adverse effects | Candidiasis - drug therapy | Clindamycin - administration & dosage | Aged, 80 and over | Adult | Female | Anti-Bacterial Agents - adverse effects | Colistin - adverse effects | Odds Ratio | Drug Resistance, Fungal | Bacterial Infections - microbiology | Candidemia - microbiology | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Bacterial Infections - drug therapy | Risk Factors | Colistin - administration & dosage | Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects | Carbapenems - adverse effects | Candidiasis - etiology | Candidemia - drug therapy | Aged | Israel | Anti-Bacterial Agents - administration & dosage | Antifungal Agents - administration & dosage | Candidemia - etiology | Candida glabrata - drug effects | Index Medicus | Drugs | Colistin | Clindamycin | Drug resistance | Risk factors | Infection | Antibiotics | azoles | trimethoprim-sulfamethoxazole | Models | Candidemia | Metronidazole | Carbapenems | Epidemiology and Surveillance
Journal Article
Modern rheumatology, ISSN 1439-7595, 7/2013, Volume 23, Issue 4, pp. 752 - 758
To investigate the safety and efficacy of a dose-escalation regimen of trimethoprim–sulfamethoxazole (TMP/SMX) for prophylaxis against Pneumocystis jiroveci... 
Desensitization | Medicine & Public Health | Dose escalation | Orthopedics | Rheumatology | Prophylaxis | Pneumocystis jiroveci pneumonia | Trimethoprim–sulfamethoxazole | Trimethoprim-sulfamethoxazole | Life Sciences & Biomedicine | Science & Technology | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2013, Volume 57, Issue 2, pp. 855 - 863
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Linezolid | Skin - microbiology | Mupirocin - administration & dosage | Male | Luminescent Measurements | Mupirocin - therapeutic use | Oxazolidinones - administration & dosage | Skin - injuries | Oxazolidinones - therapeutic use | Anti-Bacterial Agents - therapeutic use | Doxycycline - administration & dosage | Staphylococcal Skin Infections - drug therapy | Acetamides - therapeutic use | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Clindamycin - administration & dosage | Community-Acquired Infections - drug therapy | Diabetes Mellitus, Type 2 | Soft Tissue Infections - drug therapy | Staphylococcal Infections - microbiology | Wound Healing - drug effects | Daptomycin - therapeutic use | Disease Models, Animal | Staphylococcal Infections - drug therapy | Vancomycin - administration & dosage | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Administration, Oral | Doxycycline - therapeutic use | Methicillin-Resistant Staphylococcus aureus - drug effects | Mice, Inbred C57BL | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Bacterial Load | Clindamycin - therapeutic use | Animals | Soft Tissue Infections - microbiology | Vancomycin - therapeutic use | Mice | Administration, Topical | Anti-Bacterial Agents - administration & dosage | Community-Acquired Infections - microbiology | Staphylococcal Skin Infections - microbiology | Daptomycin - administration & dosage | Acetamides - administration & dosage | Index Medicus | Animal models | Bioluminescence | Intravenous administration | Image processing | Clindamycin | Vancomycin | Cellulitis | Drug resistance | Polyethylene glycol | Surgery | daptomycin | Ointments | Wound infection | Wound healing | Diabetes mellitus | Antimicrobial agents | Folliculitis | Mupirocin | imaging | Soft tissues | Drainage | Photography | Antibiotics | trimethoprim-sulfamethoxazole | Ulcers | Doxycycline | Impetigo | Skin | Experimental Therapeutics
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2008, Volume 52, Issue 6, pp. 2156 - 2162
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Linezolid | Humans | Doxycycline - pharmacokinetics | Drug Resistance, Bacterial | Acetamides - pharmacology | Colony Count, Microbial | Clindamycin - pharmacokinetics | Clindamycin - pharmacology | Oxazolidinones - therapeutic use | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Acetamides - therapeutic use | Culture Media | Vancomycin - pharmacology | Staphylococcal Infections - microbiology | Methicillin Resistance | Daptomycin - therapeutic use | Disease Models, Animal | Staphylococcus aureus - genetics | Trimethoprim, Sulfamethoxazole Drug Combination - pharmacokinetics | Acetamides - pharmacokinetics | Doxycycline - therapeutic use | Oxazolidinones - pharmacokinetics | Thigh - microbiology | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Clindamycin - therapeutic use | Daptomycin - pharmacology | Animals | Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology | Staphylococcus aureus - classification | Vancomycin - pharmacokinetics | Oxazolidinones - pharmacology | Vancomycin - therapeutic use | Anti-Bacterial Agents - pharmacokinetics | Daptomycin - pharmacokinetics | Doxycycline - pharmacology | Anti-Bacterial Agents - pharmacology | Mice | Staphylococcus aureus - drug effects | Staphylococcus aureus - growth & development | Community-Acquired Infections - microbiology | Index Medicus | Experimental Therapeutics
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2017, Volume 376, Issue 26, pp. 2545 - 2555
There are limited data on the role of antimicrobials in the treatment of skin abscesses. In this trial, clindamycin or trimethoprim–sulfamethoxazole was found... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Prospective Studies | Humans | Child, Preschool | Infant | Male | Skin Diseases, Bacterial - drug therapy | Anti-Bacterial Agents - therapeutic use | Clindamycin - adverse effects | Staphylococcal Skin Infections - drug therapy | Abscess - therapy | Adult | Female | Abscess - drug therapy | Anti-Bacterial Agents - adverse effects | Child | Double-Blind Method | Staphylococcus aureus - isolation & purification | Combined Modality Therapy | Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Clindamycin - therapeutic use | Drainage | Skin Diseases, Bacterial - therapy | Adolescent | Intention to Treat Analysis | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Care and treatment | Usage | Clindamycin | Patient outcomes | Surgery | Abscess | Staphylococcus aureus infections | Causes of | Dosage and administration | Drug therapy | Complications | Hypersensitivity | Clinical trials | Trimethoprim | Staphylococcus infections | Antimicrobial agents | Wound drainage | Cellulitis | Drug resistance | Clinical outcomes | Methicillin | Studies | Trimethoprim-sulfamethoxazole | Sulfamethoxazole | Side effects | Motivation | Antibiotics | Abscesses | Skin | Children | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2017, Volume 377, Issue 3, pp. 233 - 245
Journal Article